Jan. 3, 2013, 5:18 PMAfter reviewing guidance for FY13 back in November, Hologic (HOLX) has decided to sell its Lifecodes business unit to Immucor (BLUD). Under the terms, HOLX will receive $85M in cash at closing and have the opportunity to earn a contingent payment of $10M based on achievement of certain financial targets throughout 2013. The transaction is expected to close during Q2. | Jan. 3, 2013, 5:18 PM | Comment!
Jul. 21, 2011, 12:10 AM
Founded in 1982, Immucor, Inc., a Georgia corporation, develops, manufactures and sells a complete line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. Our offerings are targeted... More
Other News & PR